Abstract
Mainly restricted to the nervous system in healthy adults, complex gangliosides such as GD3 and GD2 have been shown to be involved in aggressiveness and metastasis of neuro-ectoderm derived tumors such as melanoma and neuroblastoma. Interestingly, O-acetylated forms of GD2, not expressed in human peripheral nerve fibers, are highly expressed in GD2+ tumor cells. Very little information is known regarding the expression of O-acetylated disialogangliosides in breast cancer (BC) cell lines. Here, we analyzed the expression of GD2, GD3 and their O-acetylated forms O-acetyl-GD2 (OAcGD2) and O-acetyl-GD3 (OAcGD3) in BC cells. We used Hs 578T and SUM159PT cell lines, as well as cell clones over-expressing GD3 synthase derived from MDA-MB-231 and MCF-7. Using flow cytometry and immunocytochemistry/confocal microscopy, we report that BC cells express b-series gangliosides GD3 and GD2, as well as significant amounts of OAcGD2. However, OAcGD3 expression was not detected in these cells. O-acetylation of gangliosides isolated from BC cells was examined by LC-MS analysis of sialic acid DMB-derivatives. We report that the main acetylated form of sialic acid expressed in BC gangliosides is 9-O-acetyl-N-acetylneuraminic acid (Neu5,9Ac2). These results highlight a close interrelationship between Neu5,9Ac2 and OAcGD2 expression, and suggest that OAcGD2 is synthetized from GD2 and not from OAcGD3 in BC cells.
Similar content being viewed by others
Abbreviations
- BC:
-
Breast Cancer
- BSM:
-
Bovine Submaxillary Mucin
- CMP Neu5Ac:
-
cytidine-monophosphate N-acetylneuraminic acid
- DMB:
-
1,2-diamino-4,5-methylenedioxybenzene
- ER:
-
Estrogen Receptor
- Gal:
-
Galactose
- GalNAc:
-
N-acetylgalacotosamine
- GD2S:
-
GD2 synthase
- GD3S:
-
GD3 synthase
- GT:
-
Glycosyltransferase
- HPRT:
-
Hypoxanthine-guanine PhosphoRibosylTransferase
- LacCer:
-
Lactosyl-ceramide
- LC/ESI-MS:
-
Liquid Chromatography/ Electrospray ionization coupled to Mass Spectrometry
- mAb:
-
monoclonal antibody
- MFI:
-
Mean Fluorescence Intensity
- Neu5Ac:
-
N-acetylneuraminic acid
- Neu5,8Ac2 :
-
8-O-acetyl-N-acetylneuraminic acid
- Neu5,9Ac2 :
-
9-O-acetyl-N-acetylneuraminic acid
- OAcGD2:
-
O-acetyl-GD2
- OAcGD3 :
-
O-acetyl-GD3.
- TACA:
-
Tumor-Associated Carbohydrate Antigens
- TNBC:
-
Triple Negative Breast Cancer
References
Hakomori, S.: Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res. 45(6), 2405–2414 (1985)
Yoshida, S., Fukumoto, S., Kawaguchi, H., Sato, S., Ueda, R., Furukawa, K., Ganglioside, G.: (D2) in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis. Cancer Res. 61(10), 4244–4252 (2001)
Yu, A.L., Gilman, A.L., Ozkaynak, M.F., London, W.B., Kreissman, S.G., Chen, H.X., Smith, M., Anderson, B., Villablanca, J.G., Matthay, K.K., Shimada, H., Grupp, S.A., Seeger, R., Reynolds, C.P., Buxton, A., Reisfeld, R.A., Gillies, S.D., Cohn, S.L., Maris, J.M., Sondel, P.M., Children's Oncology, G.: Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N. Engl. J. Med. 363(14), 1324–1334 (2010). https://doi.org/10.1056/NEJMoa0911123
Dhillon, S.: Dinutuximab: first global approval. Drugs. 75(8), 923–927 (2015). https://doi.org/10.1007/s40265-015-0399-5
Alvarez-Rueda, N., Desselle, A., Cochonneau, D., Chaumette, T., Clemenceau, B., Leprieur, S., Bougras, G., Supiot, S., Mussini, J.M., Barbet, J., Saba, J., Paris, F., Aubry, J., Birkle, S.: A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivity. PLoS One. 6(9), e25220 (2011). https://doi.org/10.1371/journal.pone.0025220
Malisan, F., Franchi, L., Tomassini, B., Ventura, N., Condo, I., Rippo, M.R., Rufini, A., Liberati, L., Nachtigall, C., Kniep, B., Testi, R.: Acetylation suppresses the proapoptotic activity of GD3 ganglioside. J. Exp. Med. 196(12), 1535–1541 (2002)
Mukherjee, K., Chava, A.K., Mandal, C., Dey, S.N., Kniep, B., Chandra, S., Mandal, C.: O-acetylation of GD3 prevents its apoptotic effect and promotes survival of lymphoblasts in childhood acute lymphoblastic leukaemia. J. Cell. Biochem. 105(3), 724–734 (2008). https://doi.org/10.1002/jcb.21867
Recchi, M.A., Hebbar, M., Hornez, L., Harduin-Lepers, A., Peyrat, J.P., Delannoy, P.: Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res. 58(18), 4066–4070 (1998)
Marquina, G., Waki, H., Fernandez, L.E., Kon, K., Carr, A., Valiente, O., Perez, R., Ando, S.: Gangliosides expressed in human breast cancer. Cancer Res. 56(22), 5165–5171 (1996)
Ruckhaberle, E., Karn, T., Rody, A., Hanker, L., Gatje, R., Metzler, D., Holtrich, U., Kaufmann, M.: Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer. J. Cancer Res. Clin. Oncol. 135(8), 1005–1013 (2009). https://doi.org/10.1007/s00432-008-0536-6
Cazet, A., Groux-Degroote, S., Teylaert, B., Kwon, K.M., Lehoux, S., Slomianny, C., Kim, C.H., Le Bourhis, X., Delannoy, P.: GD3 synthase overexpression enhances proliferation and migration of MDA-MB-231 breast cancer cells. Biol. Chem. 390(7), 601–609 (2009). https://doi.org/10.1515/BC.2009.054
Cazet, A., Julien, S., Bobowski, M., Krzewinski-Recchi, M.A., Harduin-Lepers, A., Groux-Degroote, S., Delannoy, P.: Consequences of the expression of sialylated antigens in breast cancer. Carbohydr. Res. 345(10), 1377–1383 (2010). https://doi.org/10.1016/j.carres.2010.01.024
Steenackers, A., Vanbeselaere, J., Cazet, A., Bobowski, M., Rombouts, Y., Colomb, F., Le Bourhis, X., Guerardel, Y., Delannoy, P.: Accumulation of unusual gangliosides G(Q3) and G(P3) in breast cancer cells expressing the G(D3) synthase. Molecules. 17(8), 9559–9572 (2012). https://doi.org/10.3390/molecules17089559
Mandal, C., Schwartz-Albiez, R., Vlasak, R.: Functions and biosynthesis of O-acetylated sialic acids. Top. Curr. Chem. 366, 1–30 (2015). https://doi.org/10.1007/128_2011_310
Baumann, A.M., Bakkers, M.J., Buettner, F.F., Hartmann, M., Grove, M., Langereis, M.A., de Groot, R.J., Muhlenhoff, M.: 9-O-acetylation of sialic acids is catalysed by CASD1 via a covalent acetyl-enzyme intermediate. Nat. Commun. 6(7673), (2015). https://doi.org/10.1038/ncomms8673
Mandal, C., Srinivasan, G.V., Chowdhury, S., Chandra, S., Mandal, C., Schauer, R., Mandal, C.: High level of sialate-O-acetyltransferase activity in lymphoblasts of childhood acute lymphoblastic leukaemia (ALL): enzyme characterization and correlation with disease status. Glycoconj. J. 26(1), 57–73 (2009). https://doi.org/10.1007/s10719-008-9163-3
Ravindranath, M.H., Higa, H.H., Cooper, E.L., Paulson, J.C.: Purification and characterization of an O-acetylsialic acid-specific lectin from a marine crab Cancer antennarius. J. Biol. Chem. 260(15), 8850–8856 (1985)
Sharma, V., Chatterjee, M., Mandal, C., Sen, S., Basu, D.: Rapid diagnosis of Indian visceral leishmaniasis using achatininH, a 9-O-acetylated sialic acid binding lectin. Am J Trop Med Hyg. 58(5), 551–554 (1998)
Zimmer, G., Suguri, T., Reuter, G., Yu, R.K., Schauer, R., Herrler, G.: Modification of sialic acids by 9-O-acetylation is detected in human leucocytes using the lectin property of influenza C virus. Glycobiology. 4(3), 343–349 (1994)
Ravindranaths, M.H., Paulson, J.C., Irie, R.F.: Human melanoma antigen O-acetylated ganglioside GD3 is recognized by Cancer antennarius lectin. J. Biol. Chem. 263(4), 2079–2086 (1988)
Saito, M., Kasai, N.: Yu, R.K.: in situ immunological determination of basic carbohydrate structures of gangliosides on thin-layer plates. Anal. Biochem. 148(1), 54–58 (1985)
Cerato, E., Birkle, S., Portoukalian, J., Mezazigh, A., Chatal, J.F., Aubry, J.: Variable region gene segments of nine monoclonal antibodies specific to disialogangliosides (GD2, GD3) and their O-acetylated derivatives. Hybridoma. 16(4), 307–316 (1997). https://doi.org/10.1089/hyb.1997.16.307
Steenackers, A., Cazet A., Bobowski M., Rombouts Y., Lefebvre J., Guérardel Y., Tulasne D., Le Bourhis X., Delannoy P.: Expression of GD3 synthase modifies ganglioside profile and increases migration of MCF-7 breast cancer cells. C.R. Chimie 15, 3–14 (2012)
Pfaffl, M.W.: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29(9), e45 (2001)
Klein, A., Diaz, S., Ferreira, I., Lamblin, G., Roussel, P., Manzi, A.E.: New sialic acids from biological sources identified by a comprehensive and sensitive approach: liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) of SIA quinoxalinones. Glycobiology. 7(3), 421–432 (1997)
Sommer, U., Herscovitz, H., Welty, F.K., Costello, C.E.: LC-MS-based method for the qualitative and quantitative analysis of complex lipid mixtures. J. Lipid Res. 47(4), 804–814 (2006). https://doi.org/10.1194/jlr.M500506-JLR200
Bobowski, M., Vincent, A., Steenackers, A., Colomb, F., Van Seuningen, I., Julien, S., Delannoy, P.: Estradiol represses the G(D3) synthase gene ST8SIA1 expression in human breast cancer cells by preventing NFkappaB binding to ST8SIA1 promoter. PLoS One. 8(4), e62559 (2013). https://doi.org/10.1371/journal.pone.0062559
Groux-Degroote, S., Guerardel, Y., Delannoy, P.: Gangliosides: structures, biosynthesis, analysis, and roles in Cancer. Chembiochem. 18(13), 1146–1154 (2017). https://doi.org/10.1002/cbic.201600705
Hamamura, K., Furukawa, K., Hayashi, T., Hattori, T., Nakano, J., Nakashima, H., Okuda, T., Mizutani, H., Hattori, H., Ueda, M., Urano, T., Lloyd, K.O., Furukawa, K.: Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells. Proc. Natl. Acad. Sci. U. S. A. 102(31), 11041–11046 (2005). https://doi.org/10.1073/pnas.0503658102
Cazet, A., Bobowski, M., Rombouts, Y., Lefebvre, J., Steenackers, A., Popa, I., Guerardel, Y., Le Bourhis, X., Tulasne, D., Delannoy, P.: The ganglioside G(D2) induces the constitutive activation of c-met in MDA-MB-231 breast cancer cells expressing the G(D3) synthase. Glycobiology. 22(6), 806–816 (2012). https://doi.org/10.1093/glycob/cws049
Fleurence, J., Cochonneau, D., Fougeray, S., Oliver, L., Geraldo, F., Terme, M., Dorvillius, M., Loussouarn, D., Vallette, F., Paris, F., Birkle, S.: Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside. Oncotarget. 7(27), 41172–41185 (2016). https://doi.org/10.18632/oncotarget.9226
Terme, M., Dorvillius, M., Cochonneau, D., Chaumette, T., Xiao, W., Diccianni, M.B., Barbet, J., Yu, A.L., Paris, F., Sorkin, L.S., Birkle, S.: Chimeric antibody c.8B6 to O-acetyl-GD2 mediates the same efficient anti-neuroblastoma effects as therapeutic ch14.18 antibody to GD2 without antibody induced allodynia. PLoS One. 9(2), e87210 (2014). https://doi.org/10.1371/journal.pone.0087210
Cochonneau, D., Terme, M., Michaud, A., Dorvillius, M., Gautier, N., Frikeche, J., Alvarez-Rueda, N., Bougras, G., Aubry, J., Paris, F., Birkle, S.: Cell cycle arrest and apoptosis induced by O-acetyl-GD2-specific monoclonal antibody 8B6 inhibits tumor growth in vitro and in vivo. Cancer Lett. 333(2), 194–204 (2013). https://doi.org/10.1016/j.canlet.2013.01.032
Cheresh, D.A., Pierschbacher, M.D., Herzig, M.A., Mujoo, K.: Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins. J. Cell Biol. 102(3), 688–696 (1986)
Kohla, G., Stockfleth, E., Schauer, R.: Gangliosides with O-acetylated sialic acids in tumors of neuroectodermal origin. Neurochem. Res. 27(7–8), 583–592 (2002)
Furukawa, K., Aixinjueluo, W., Kasama, T., Ohkawa, Y., Yoshihara, M., Ohmi, Y., Tajima, O., Suzumura, A., Kittaka, D., Furukawa, K.: Disruption of GM2/GD2 synthase gene resulted in overt expression of 9-O-acetyl GD3 irrespective of Tis21. J. Neurochem. 105(3), 1057–1066 (2008). https://doi.org/10.1111/j.1471-4159.2008.05232.x
Fuller, M., Duplock, S., Hein, L.K., Rigat, B.A., Mahuran, D.J.: Liquid chromatography/electrospray ionisation-tandem mass spectrometry quantification of GM2 gangliosides in human peripheral cells and plasma. Anal. Biochem. 458, 20–26 (2014). https://doi.org/10.1016/j.ab.2014.04.018
Barrientos, R.C., Zhang, Q.: Isobaric labeling of intact gangliosides toward multiplexed LC-MS/MS-based quantitative analysis. Anal. Chem. 90(4), 2578–2586 (2018). https://doi.org/10.1021/acs.analchem.7b04044
Sjoberg, E.R., Manzi, A.E., Khoo, K.H., Dell, A., Varki, A.: Structural and immunological characterization of O-acetylated GD2. Evidence that GD2 is an acceptor for ganglioside O-acetyltransferase in human melanoma cells. J. Biol. Chem. 267(23), 16200–16211 (1992)
Ren, S., Ariga, T., Scarsdale, J.N., Zhang, Y., Slominski, A., Livingston, P.O., Ritter, G., Kushi, Y.: Yu, R.K.: characterization of a hamster melanoma-associated ganglioside antigen as 7-O-acetylated disialoganglioside GD3. J. Lipid Res. 34(9), 1565–1572 (1993)
Acknowledgements
We thank Christian Slomianny of the BICeL-Campus Lille1 (Univ. Lille, Bio Imaging Center Lille, F-59000 Lille, France) facility for access to instruments and technical advices. We are indebted to the PAGés plateform (Plateforme d’Analyses des Glycoconjugués, CNRS, UMR 8576, UGSF, Université de Lille), F-59000 Lille, France for the use of the mass spectrometer.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflicts of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cavdarli, S., Dewald, J.H., Yamakawa, N. et al. Identification of 9-O-acetyl-N-acetylneuraminic acid (Neu5,9Ac2) as main O-acetylated sialic acid species of GD2 in breast cancer cells. Glycoconj J 36, 79–90 (2019). https://doi.org/10.1007/s10719-018-09856-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-018-09856-w